Conduction System Pacing
17
9
11
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (17)
Left Bundle Branch Area Pacing (LBBAP) PMCF Study
A Comparison of Left Bundle Branch Optimized Cardiac Resynchronization Therapy vs Left Bundle Branch Area Pacing Alone
Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
Conduction System Pacing vs. Biventricular Pacing for Cardiac Resynchronization Therapy
Left Bundle Branch Area Pacing Versus Right Ventricular Pacing in Atrioventricular Block With Preserved Ejection Fraction
Impact of Atrioventricular Delay Optimization on Ventricular Function in Conduction System Pacing
CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy
Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy
Central Haemodynamics and Pacing for AV Block
Study of AHRE Burden in Patients Undergoing Bachmann Bundle Area Pacing and Left Bundle Branch Pacing.
Fluoroless Conduction System Implant
Solutions to the Challenges of Conduction System Pacing
Conduction System Pacing vs Biventricular Resynchronization Therapy in Systolic Dysfunction and Wide QRS: CONSYST-CRT.
Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure
Left Bundle Branch Area Pacing in Patients With Heart Failure
LVSP vs RVP in Patients With AV Conduction Disorders
Long-term Outcomes of Conduction System Pacing: a National Multicenter Observational Study - NORMAND'HIS / STIMU'HIS